In addition, using the BLM mouse model of lung fibrosis, we demonstrate that therapeutic dosing with an ST2-Fc fusion protein has no effect on the severity of established BLM-induced fibrosis. The gene discussed is IL1RL1; the disease is pulmonary fibrosis.